Systemic redox imbalance in patients with nonalcoholic fatty liver disease

被引:17
|
作者
Asghari, Somayyeh [1 ]
Hamedi-Shahraki, Soudabeh [2 ]
Amirkhizi, Farshad [3 ]
机构
[1] Tabriz Univ Med Sci, Fac Nutr & Food Sci, Dept Community Nutr, Tabriz, Iran
[2] Zabol Univ Med Sci, Fac Publ Hlth, Dept Epidemiol & Biostat, Zabol, Iran
[3] Zabol Univ Med Sci, Fac Publ Hlth, Dept Nutr, Zabol, Iran
关键词
hepatic steatosis; liver enzymes; nonalcoholic fatty liver disease; oxidative stress; systemic redox; OXIDATIVE STRESS; LIPID-PEROXIDATION; HEPATIC STEATOSIS; STEATOHEPATITIS; ASSOCIATION; MECHANISMS;
D O I
10.1111/eci.13211
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Oxidative stress is one of the major pathologic mechanisms for the progression of nonalcoholic fatty liver disease (NAFLD). The aim of this study was to evaluate the relationship between the extent of steatosis and oxidative stress parameters in patients with NAFLD. Methods The data obtained from 122 patients with NAFLD and 106 healthy controls aged 20-60 years with body mass index (BMI) ranging from 25 to 35 kg/m(2). Abdominal ultrasonography was performed in participants in order to the grading of hepatic steatosis. Fasting blood samples and anthropometric measurements were collected for all study subjects. Oxidative stress was evaluated by measurement of serum malondialdehyde (MDA), oxidized low-density lipoprotein (ox-LDL), total antioxidant capacity (TAC) and erythrocyte superoxide dismutase (SOD) as well as glutathione peroxidase (GPx) activities. Results Serum levels of liver enzymes (P < .0001) and MDA (P = .018), as well as erythrocyte SOD activity (P < .0001), were significantly higher in patients with NAFLD compared to healthy controls. Furthermore, patients with NAFLD had significantly lower serum TAC levels compared to healthy controls (P < .0001). No significant differences were observed in serum ox-LDL level and erythrocyte GPx activity between the groups. The probability of being NAFLD increased with increasing serum levels of MDA (P = .020) and SOD activity (P < .0001). In contrast, decreased serum TAC levels predicted the probability of being NAFLD (P < .0001). Conclusions Increased extent of hepatic steatosis could be considered as a pathological mechanism for enhancing oxidative stress in patients with NAFLD, independent of obesity, and is exacerbated further in patients with more severe condition.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Comparative redox status in alcoholic liver disease and nonalcoholic fatty liver disease
    Payal Bhardwaj
    Kaushal Madan
    Sandeep Thareja
    Yogendra Kumar Joshi
    Anoop Saraya
    [J]. Hepatology International, 2008, 2 : 202 - 208
  • [2] Comparative redox status in alcoholic liver disease and nonalcoholic fatty liver disease
    Bhardwaj, Payal
    Madan, Kaushal
    Thareja, Sandeep
    Joshi, Yogendra Kumar
    Saraya, Anoop
    [J]. HEPATOLOGY INTERNATIONAL, 2008, 2 (02) : 202 - 208
  • [3] Nonalcoholic fatty liver disease as a multi-systemic disease
    Fotbolcu, Hakan
    Zorlu, Elcin
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (16) : 4079 - 4090
  • [4] Nonalcoholic fatty liver disease as a multi-systemic disease
    Hakan Fotbolcu
    El?in Zorlu
    [J]. World Journal of Gastroenterology, 2016, (16) : 4079 - 4090
  • [5] Nonalcoholic fatty liver disease in patients with psoriasis: a consequence of systemic inflammatory burden?
    Prussick, R. B.
    Miele, L.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (01) : 16 - 29
  • [6] Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease
    Yesilova, Z
    Yaman, H
    Oktenli, C
    Ozcan, A
    Uygun, A
    Cakir, E
    Sanisoglu, Y
    Erdil, A
    Ates, Y
    Aslan, M
    Musabak, U
    Erbil, K
    Karaeren, N
    Dagalp, K
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (04): : 850 - 855
  • [7] Selenium Metabolism and Systemic Inflammation in Hypertensive Patients with Nonalcoholic Fatty Liver Disease
    Tverezovska, Iryna
    Zhelezniakova, Natalia
    [J]. AMERICAN HEART JOURNAL, 2022, 254 : 252 - 252
  • [8] Prevalence and Predictors of Nonalcoholic Fatty Liver Disease in Family Members of Patients With Nonalcoholic Fatty Liver Disease
    Anand, Abhinav
    Singh, Amit A.
    Elhence, Anshuman
    Vaishnav, Manas
    Biswas, Sagnik
    Gunjan, Deepak
    Gamanagatti, Shivanand R.
    Nayak, Baibaswata
    Kumar, Ramesh
    Shalimar
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 12 (02) : 362 - 371
  • [9] Systemic Redox Imbalance in Patients with Chronic Granulomatous Disease
    Heropolitanska-Pliszka, Edyta
    Berk, Klaudia
    Maciejczyk, Mateusz
    Sawicka-Powierza, Jolanta
    Bernatowska, Ewa
    Wolska-Kusnierz, Beata
    Pac, Malgorzata
    Dabrowska-Leonik, Nel
    Piatosa, Barbara
    Lewandowicz-Uszynska, Aleksandra
    Karpinska, Joanna
    Zalewska, Anna
    Mikoluc, Bozena
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (05)
  • [10] Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh
    Alam, Shahinul
    Noor-E-Alam, Sheikh Mohammad
    Chowdhury, Ziaur Rahman
    Alam, Mahabubul
    Kabir, Jahangir
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2013, 5 (05) : 281 - 287